TrialDigestion2025

Effects of a Protease Inhibitor Camostat Mesilate on Gut Microbial Function in Patients with Irritable Bowel Syndrome: A Pilot Randomized Placebo-Controlled Study.

Motoyori Kanazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.